Abstract 10202: DNA-PKcs: A Novel Therapeutic Target in Pulmonary Arterial Hypertension
Keiko Yamamoto(Institut universitaire de cardiologie et de pneumologie de Québec), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Kana Shimauchi(Canadian Heart Research Centre), Tetsuro Yokokawa(Fukushima Medical University), Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec), Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Tsukasa Shimauchi(Kyushu University), Olivier Boucherat, Valérie Nadeau, Sandra Breuils Bonnet(Université Laval), Mabrouka Salem(King Khalid University), Alice Bourgeois, François Potus(Queen's University)
Cited by 0
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Novel Mutations and Decreased Expression of the Epigenetic Regulator <i>TET2</i> in Pulmonary Arterial Hypertension
|Circulation|2020|120
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
|Genetics in Medicine|2023|73
TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy
|JCI Insight|2017|66
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension
|American Journal of Respiratory and Critical Care Medicine|2020|34